Myriad Genetics | Beneficio Operativo



Operating Profit Cambio Fecha
Agilent USD 376M 32M 2025-01
Becton, Dickinson and Co. USD 453M 195M 2024-12
Bio-Rad Laboratories USD 58.4M 6.07M 2024-12
Bruker USD 64.1M 4M 2024-12
Danaher USD 1.42B 467M 2024-12
Exact Sciences USD -876351000 836.95M 2024-12
Hologic USD 229.8M 200K 2024-12
Illumina USD 175M 566M 2024-12
J&J USD 3.89B 549M 2024-12
Mettler Toledo International USD 314.55M 295.95M 2024-12
Myriad Genetics USD -39000000 19M 2024-12
Quest Diagnostics USD 361M 8M 2024-12
Quidel USD -100400000 115.4M 2024-12
Repligen USD -7830000 10.29M 2024-09
Revvity USD 118.75M 20.6M 2024-12
Standard Biotools USD -32817000 1.1M 2024-12
Thermo Fisher Scientific USD 2.02B 178M 2024-12
Veracyte USD 4.18M 7.84M 2024-12
Waters USD 292.26M 81.13M 2024-12



Myriad Genetics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.